Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
5/22/2026
Recent Executive Moves
5/22/2026
Bayer Wins China Approval for Kerendia (finerenone) in Heart Failure
5/22/2026
Qyuns Therapeutics Expands China Biologics Portfolio With Ustekinumab ...
5/22/2026
J&J Wins China Approval for Nipocalimab in Myasthenia Gravis
5/22/2026
Nuance Wins China IND Clearance for Actair Allergy Immunotherapy Trial
5/22/2026
Pakistan Emerges as New Target for Chinese Pharmaceutical Investment
5/22/2026
FDA Warns Chinese API Manufacturer Over Relabeled GLP-1 Ingredients Sh...
5/22/2026
Full-Life Raises $150M to Expand Clinical Radiopharma Pipeline and Act...
5/22/2026
China Clears First INDs for 25 Novel Drugs Last Week
5/21/2026
China to Establish "Whitelist" System to Curb Misuse of Medical Insura...
5/21/2026
China Accelerates Stem Cell Race for Parkinson's Disease Therapies
5/21/2026
United Labs Wins China IND Clearance for Novel Broad-Spectrum β-Lacta...
5/21/2026
20n Bio Raises $7.5M Seed+ Round for AI-Driven Macrocyclic Peptide Pla...
5/21/2026
Forlong Biotech Raises ~CNY 100M to Advance Cytokine Therapy Pipeline
5/21/2026
Neuregen Raises Series A to Advance In-Vivo Cell Reprogramming Pipelin...
5/20/2026
China Tightens Standards for Generic Drug CMC and Bioequivalence Studi...
5/20/2026
CDE Issues M13A Implementation Guidance and First Low-Risk Formulation...
5/20/2026
China Adopts ICH M13A Bioequivalence Guideline for Oral Immediate-Rele...
5/19/2026
China Tightens Oversight of Employee BMI Accounts at Retail Pharmacies
5/19/2026
Merck's China-Licensed ADC Succeeds in First Global Phase 3 Trial
5/19/2026
China Advances Parrot Fever and Ebola Vaccine Programs
5/19/2026
CSPC Wins China Approval to Begin Clinical Trials for First-in-Class K...
5/19/2026
Novartis Terminates Partnership with Chinese CDMO Porton
5/19/2026
Bivision Raises CNY 400M to Advance Targeted Radionuclide Therapy Pipe...
5/19/2026
Akeso Reports Encouraging Phase II AML Data for Anti-CD47 Antibody Lig...
5/19/2026
China's 12th Centralized Drug Procurement Expands to Record 70+ Drug V...
5/19/2026
Vincentage Posts Phase III Obesity Data as Oral GLP-1 Race in China He...
5/19/2026
Accro Bioscience Raises $50M Series C to Advance UC Pipeline
5/18/2026
Harbour BioMed Unveils Promising Preclinical Data for AI-Designed Obes...
5/18/2026
AbbVie's Epcoritamab Wins First China Approval for Relapsed or Refract...
Page:
1
/
63
Total number of articles:
1866
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit